nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—prostate cancer—bone cancer	0.946	1	CtDrD
Degarelix—Inflammation—Epirubicin—bone cancer	0.00031	0.00572	CcSEcCtD
Degarelix—Hepatobiliary disease—Cisplatin—bone cancer	0.00031	0.00572	CcSEcCtD
Degarelix—Bone disorder—Doxorubicin—bone cancer	0.000308	0.00569	CcSEcCtD
Degarelix—Musculoskeletal pain—Epirubicin—bone cancer	0.000304	0.00562	CcSEcCtD
Degarelix—Phosphatase alkaline increased—Epirubicin—bone cancer	0.000301	0.00555	CcSEcCtD
Degarelix—Nocturia—Doxorubicin—bone cancer	0.0003	0.00554	CcSEcCtD
Degarelix—Injection site reaction—Epirubicin—bone cancer	0.000299	0.00552	CcSEcCtD
Degarelix—Blood bilirubin increased—Doxorubicin—bone cancer	0.000294	0.00543	CcSEcCtD
Degarelix—Influenza like illness—Epirubicin—bone cancer	0.000292	0.00539	CcSEcCtD
Degarelix—Urinary tract disorder—Cisplatin—bone cancer	0.00029	0.00536	CcSEcCtD
Degarelix—Urethral disorder—Cisplatin—bone cancer	0.000288	0.00532	CcSEcCtD
Degarelix—Gynaecomastia—Methotrexate—bone cancer	0.000288	0.00531	CcSEcCtD
Degarelix—Inflammation—Doxorubicin—bone cancer	0.000287	0.00529	CcSEcCtD
Degarelix—Musculoskeletal pain—Doxorubicin—bone cancer	0.000282	0.0052	CcSEcCtD
Degarelix—Phosphatase alkaline increased—Doxorubicin—bone cancer	0.000278	0.00514	CcSEcCtD
Degarelix—Injection site reaction—Doxorubicin—bone cancer	0.000277	0.0051	CcSEcCtD
Degarelix—Eye disorder—Cisplatin—bone cancer	0.000275	0.00507	CcSEcCtD
Degarelix—Cardiac disorder—Cisplatin—bone cancer	0.000273	0.00504	CcSEcCtD
Degarelix—Influenza like illness—Doxorubicin—bone cancer	0.00027	0.00499	CcSEcCtD
Degarelix—Diabetes mellitus—Methotrexate—bone cancer	0.000268	0.00495	CcSEcCtD
Degarelix—Immune system disorder—Cisplatin—bone cancer	0.000266	0.0049	CcSEcCtD
Degarelix—Mediastinal disorder—Cisplatin—bone cancer	0.000265	0.00489	CcSEcCtD
Degarelix—Arrhythmia—Cisplatin—bone cancer	0.000263	0.00485	CcSEcCtD
Degarelix—Mental disability—Epirubicin—bone cancer	0.000261	0.00482	CcSEcCtD
Degarelix—Alopecia—Cisplatin—bone cancer	0.00026	0.0048	CcSEcCtD
Degarelix—Malnutrition—Cisplatin—bone cancer	0.000256	0.00472	CcSEcCtD
Degarelix—Erythema—Cisplatin—bone cancer	0.000256	0.00472	CcSEcCtD
Degarelix—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.000251	0.00463	CcSEcCtD
Degarelix—Diabetes mellitus—Epirubicin—bone cancer	0.000251	0.00463	CcSEcCtD
Degarelix—Muscle spasms—Cisplatin—bone cancer	0.000246	0.00454	CcSEcCtD
Degarelix—Mental disability—Doxorubicin—bone cancer	0.000242	0.00446	CcSEcCtD
Degarelix—Vision blurred—Cisplatin—bone cancer	0.000241	0.00445	CcSEcCtD
Degarelix—Ill-defined disorder—Cisplatin—bone cancer	0.000238	0.00438	CcSEcCtD
Degarelix—Anaemia—Cisplatin—bone cancer	0.000237	0.00437	CcSEcCtD
Degarelix—Hot flush—Epirubicin—bone cancer	0.000233	0.00431	CcSEcCtD
Degarelix—Diabetes mellitus—Doxorubicin—bone cancer	0.000232	0.00429	CcSEcCtD
Degarelix—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.000232	0.00429	CcSEcCtD
Degarelix—Menopausal symptoms—Epirubicin—bone cancer	0.000231	0.00427	CcSEcCtD
Degarelix—Malaise—Cisplatin—bone cancer	0.000231	0.00426	CcSEcCtD
Degarelix—Renal impairment—Epirubicin—bone cancer	0.000229	0.00423	CcSEcCtD
Degarelix—Cardiac failure—Epirubicin—bone cancer	0.000224	0.00413	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000216	0.00399	CcSEcCtD
Degarelix—Hot flush—Doxorubicin—bone cancer	0.000216	0.00398	CcSEcCtD
Degarelix—Discomfort—Cisplatin—bone cancer	0.000215	0.00397	CcSEcCtD
Degarelix—Menopausal symptoms—Doxorubicin—bone cancer	0.000214	0.00395	CcSEcCtD
Degarelix—Renal impairment—Doxorubicin—bone cancer	0.000212	0.00392	CcSEcCtD
Degarelix—Breast disorder—Methotrexate—bone cancer	0.000211	0.00389	CcSEcCtD
Degarelix—Anaphylactic shock—Cisplatin—bone cancer	0.000209	0.00386	CcSEcCtD
Degarelix—Cardiac failure—Doxorubicin—bone cancer	0.000207	0.00382	CcSEcCtD
Degarelix—Nervous system disorder—Cisplatin—bone cancer	0.000205	0.00378	CcSEcCtD
Degarelix—Skin disorder—Cisplatin—bone cancer	0.000203	0.00375	CcSEcCtD
Degarelix—Hyperhidrosis—Cisplatin—bone cancer	0.000202	0.00373	CcSEcCtD
Degarelix—Breast disorder—Epirubicin—bone cancer	0.000197	0.00364	CcSEcCtD
Degarelix—Hypotension—Cisplatin—bone cancer	0.000195	0.0036	CcSEcCtD
Degarelix—Abdominal discomfort—Methotrexate—bone cancer	0.000193	0.00357	CcSEcCtD
Degarelix—Muscular weakness—Epirubicin—bone cancer	0.000193	0.00355	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00019	0.00351	CcSEcCtD
Degarelix—Dysuria—Methotrexate—bone cancer	0.000189	0.00348	CcSEcCtD
Degarelix—Dyspnoea—Cisplatin—bone cancer	0.000186	0.00344	CcSEcCtD
Degarelix—Erectile dysfunction—Methotrexate—bone cancer	0.000186	0.00343	CcSEcCtD
Degarelix—Breast disorder—Doxorubicin—bone cancer	0.000183	0.00337	CcSEcCtD
Degarelix—Decreased appetite—Cisplatin—bone cancer	0.000182	0.00335	CcSEcCtD
Degarelix—Gastrointestinal disorder—Cisplatin—bone cancer	0.00018	0.00333	CcSEcCtD
Degarelix—Depression—Methotrexate—bone cancer	0.000179	0.00331	CcSEcCtD
Degarelix—Pain—Cisplatin—bone cancer	0.000179	0.0033	CcSEcCtD
Degarelix—Muscular weakness—Doxorubicin—bone cancer	0.000178	0.00329	CcSEcCtD
Degarelix—Renal failure—Methotrexate—bone cancer	0.000177	0.00326	CcSEcCtD
Degarelix—Dysuria—Epirubicin—bone cancer	0.000176	0.00326	CcSEcCtD
Degarelix—Pollakiuria—Epirubicin—bone cancer	0.000174	0.00322	CcSEcCtD
Degarelix—Feeling abnormal—Cisplatin—bone cancer	0.000172	0.00318	CcSEcCtD
Degarelix—Weight increased—Epirubicin—bone cancer	0.000172	0.00317	CcSEcCtD
Degarelix—Weight decreased—Epirubicin—bone cancer	0.000171	0.00315	CcSEcCtD
Degarelix—Hyperglycaemia—Epirubicin—bone cancer	0.00017	0.00314	CcSEcCtD
Degarelix—Hepatobiliary disease—Methotrexate—bone cancer	0.00017	0.00314	CcSEcCtD
Degarelix—Renal failure—Epirubicin—bone cancer	0.000165	0.00305	CcSEcCtD
Degarelix—Body temperature increased—Cisplatin—bone cancer	0.000165	0.00305	CcSEcCtD
Degarelix—Urinary tract infection—Epirubicin—bone cancer	0.000164	0.00302	CcSEcCtD
Degarelix—Dysuria—Doxorubicin—bone cancer	0.000163	0.00301	CcSEcCtD
Degarelix—Pollakiuria—Doxorubicin—bone cancer	0.000161	0.00298	CcSEcCtD
Degarelix—Urinary tract disorder—Methotrexate—bone cancer	0.000159	0.00294	CcSEcCtD
Degarelix—Hepatobiliary disease—Epirubicin—bone cancer	0.000159	0.00294	CcSEcCtD
Degarelix—Weight increased—Doxorubicin—bone cancer	0.000159	0.00293	CcSEcCtD
Degarelix—Urethral disorder—Methotrexate—bone cancer	0.000158	0.00292	CcSEcCtD
Degarelix—Weight decreased—Doxorubicin—bone cancer	0.000158	0.00291	CcSEcCtD
Degarelix—Hyperglycaemia—Doxorubicin—bone cancer	0.000158	0.00291	CcSEcCtD
Degarelix—Hypersensitivity—Cisplatin—bone cancer	0.000154	0.00284	CcSEcCtD
Degarelix—Renal failure—Doxorubicin—bone cancer	0.000153	0.00282	CcSEcCtD
Degarelix—Urinary tract infection—Doxorubicin—bone cancer	0.000151	0.00279	CcSEcCtD
Degarelix—Eye disorder—Methotrexate—bone cancer	0.000151	0.00278	CcSEcCtD
Degarelix—Hypoaesthesia—Epirubicin—bone cancer	0.00015	0.00277	CcSEcCtD
Degarelix—Asthenia—Cisplatin—bone cancer	0.00015	0.00277	CcSEcCtD
Degarelix—Cardiac disorder—Methotrexate—bone cancer	0.00015	0.00276	CcSEcCtD
Degarelix—Urinary tract disorder—Epirubicin—bone cancer	0.000149	0.00275	CcSEcCtD
Degarelix—Oedema peripheral—Epirubicin—bone cancer	0.000149	0.00275	CcSEcCtD
Degarelix—Urethral disorder—Epirubicin—bone cancer	0.000148	0.00273	CcSEcCtD
Degarelix—Hepatobiliary disease—Doxorubicin—bone cancer	0.000147	0.00272	CcSEcCtD
Degarelix—Angiopathy—Methotrexate—bone cancer	0.000146	0.0027	CcSEcCtD
Degarelix—Immune system disorder—Methotrexate—bone cancer	0.000146	0.00269	CcSEcCtD
Degarelix—Mediastinal disorder—Methotrexate—bone cancer	0.000145	0.00268	CcSEcCtD
Degarelix—Chills—Methotrexate—bone cancer	0.000145	0.00267	CcSEcCtD
Degarelix—Diarrhoea—Cisplatin—bone cancer	0.000143	0.00264	CcSEcCtD
Degarelix—Alopecia—Methotrexate—bone cancer	0.000143	0.00263	CcSEcCtD
Degarelix—Mental disorder—Methotrexate—bone cancer	0.000141	0.00261	CcSEcCtD
Degarelix—Eye disorder—Epirubicin—bone cancer	0.000141	0.0026	CcSEcCtD
Degarelix—Erythema—Methotrexate—bone cancer	0.000141	0.00259	CcSEcCtD
Degarelix—Malnutrition—Methotrexate—bone cancer	0.000141	0.00259	CcSEcCtD
Degarelix—Cardiac disorder—Epirubicin—bone cancer	0.00014	0.00259	CcSEcCtD
Degarelix—Hypoaesthesia—Doxorubicin—bone cancer	0.000139	0.00257	CcSEcCtD
Degarelix—Urinary tract disorder—Doxorubicin—bone cancer	0.000138	0.00255	CcSEcCtD
Degarelix—Oedema peripheral—Doxorubicin—bone cancer	0.000138	0.00254	CcSEcCtD
Degarelix—Angiopathy—Epirubicin—bone cancer	0.000137	0.00253	CcSEcCtD
Degarelix—Urethral disorder—Doxorubicin—bone cancer	0.000137	0.00253	CcSEcCtD
Degarelix—Immune system disorder—Epirubicin—bone cancer	0.000136	0.00252	CcSEcCtD
Degarelix—Mediastinal disorder—Epirubicin—bone cancer	0.000136	0.00251	CcSEcCtD
Degarelix—Back pain—Methotrexate—bone cancer	0.000136	0.00251	CcSEcCtD
Degarelix—Chills—Epirubicin—bone cancer	0.000136	0.0025	CcSEcCtD
Degarelix—Arrhythmia—Epirubicin—bone cancer	0.000135	0.00249	CcSEcCtD
Degarelix—Alopecia—Epirubicin—bone cancer	0.000133	0.00246	CcSEcCtD
Degarelix—Vomiting—Cisplatin—bone cancer	0.000133	0.00245	CcSEcCtD
Degarelix—Vision blurred—Methotrexate—bone cancer	0.000132	0.00244	CcSEcCtD
Degarelix—Mental disorder—Epirubicin—bone cancer	0.000132	0.00244	CcSEcCtD
Degarelix—Rash—Cisplatin—bone cancer	0.000132	0.00243	CcSEcCtD
Degarelix—Dermatitis—Cisplatin—bone cancer	0.000132	0.00243	CcSEcCtD
Degarelix—Erythema—Epirubicin—bone cancer	0.000131	0.00243	CcSEcCtD
Degarelix—Malnutrition—Epirubicin—bone cancer	0.000131	0.00243	CcSEcCtD
Degarelix—Eye disorder—Doxorubicin—bone cancer	0.000131	0.00241	CcSEcCtD
Degarelix—Ill-defined disorder—Methotrexate—bone cancer	0.00013	0.00241	CcSEcCtD
Degarelix—Anaemia—Methotrexate—bone cancer	0.00013	0.0024	CcSEcCtD
Degarelix—Cardiac disorder—Doxorubicin—bone cancer	0.00013	0.00239	CcSEcCtD
Degarelix—Back pain—Epirubicin—bone cancer	0.000127	0.00235	CcSEcCtD
Degarelix—Angiopathy—Doxorubicin—bone cancer	0.000127	0.00234	CcSEcCtD
Degarelix—Malaise—Methotrexate—bone cancer	0.000127	0.00234	CcSEcCtD
Degarelix—Muscle spasms—Epirubicin—bone cancer	0.000126	0.00233	CcSEcCtD
Degarelix—Immune system disorder—Doxorubicin—bone cancer	0.000126	0.00233	CcSEcCtD
Degarelix—Mediastinal disorder—Doxorubicin—bone cancer	0.000126	0.00232	CcSEcCtD
Degarelix—Chills—Doxorubicin—bone cancer	0.000125	0.00231	CcSEcCtD
Degarelix—Arrhythmia—Doxorubicin—bone cancer	0.000125	0.0023	CcSEcCtD
Degarelix—Nausea—Cisplatin—bone cancer	0.000124	0.00229	CcSEcCtD
Degarelix—Vision blurred—Epirubicin—bone cancer	0.000124	0.00229	CcSEcCtD
Degarelix—Alopecia—Doxorubicin—bone cancer	0.000124	0.00228	CcSEcCtD
Degarelix—Mental disorder—Doxorubicin—bone cancer	0.000122	0.00226	CcSEcCtD
Degarelix—Ill-defined disorder—Epirubicin—bone cancer	0.000122	0.00225	CcSEcCtD
Degarelix—Erythema—Doxorubicin—bone cancer	0.000122	0.00224	CcSEcCtD
Degarelix—Malnutrition—Doxorubicin—bone cancer	0.000122	0.00224	CcSEcCtD
Degarelix—Anaemia—Epirubicin—bone cancer	0.000122	0.00224	CcSEcCtD
Degarelix—Arthralgia—Methotrexate—bone cancer	0.00012	0.00221	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000119	0.00219	CcSEcCtD
Degarelix—Malaise—Epirubicin—bone cancer	0.000119	0.00219	CcSEcCtD
Degarelix—Discomfort—Methotrexate—bone cancer	0.000118	0.00218	CcSEcCtD
Degarelix—Back pain—Doxorubicin—bone cancer	0.000118	0.00217	CcSEcCtD
Degarelix—Muscle spasms—Doxorubicin—bone cancer	0.000117	0.00216	CcSEcCtD
Degarelix—Palpitations—Epirubicin—bone cancer	0.000116	0.00214	CcSEcCtD
Degarelix—Anaphylactic shock—Methotrexate—bone cancer	0.000115	0.00212	CcSEcCtD
Degarelix—Vision blurred—Doxorubicin—bone cancer	0.000115	0.00212	CcSEcCtD
Degarelix—Hypertension—Epirubicin—bone cancer	0.000114	0.00209	CcSEcCtD
Degarelix—Ill-defined disorder—Doxorubicin—bone cancer	0.000113	0.00208	CcSEcCtD
Degarelix—Nervous system disorder—Methotrexate—bone cancer	0.000112	0.00207	CcSEcCtD
Degarelix—Anaemia—Doxorubicin—bone cancer	0.000112	0.00207	CcSEcCtD
Degarelix—Arthralgia—Epirubicin—bone cancer	0.000112	0.00207	CcSEcCtD
Degarelix—Skin disorder—Methotrexate—bone cancer	0.000111	0.00206	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000111	0.00205	CcSEcCtD
Degarelix—Hyperhidrosis—Methotrexate—bone cancer	0.000111	0.00205	CcSEcCtD
Degarelix—Discomfort—Epirubicin—bone cancer	0.000111	0.00204	CcSEcCtD
Degarelix—Malaise—Doxorubicin—bone cancer	0.00011	0.00202	CcSEcCtD
Degarelix—Dry mouth—Epirubicin—bone cancer	0.000109	0.00202	CcSEcCtD
Degarelix—Palpitations—Doxorubicin—bone cancer	0.000108	0.00198	CcSEcCtD
Degarelix—Anaphylactic shock—Epirubicin—bone cancer	0.000107	0.00198	CcSEcCtD
Degarelix—Hypotension—Methotrexate—bone cancer	0.000107	0.00198	CcSEcCtD
Degarelix—Nervous system disorder—Epirubicin—bone cancer	0.000105	0.00194	CcSEcCtD
Degarelix—Hypertension—Doxorubicin—bone cancer	0.000105	0.00194	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000104	0.00193	CcSEcCtD
Degarelix—Skin disorder—Epirubicin—bone cancer	0.000104	0.00192	CcSEcCtD
Degarelix—Hyperhidrosis—Epirubicin—bone cancer	0.000104	0.00191	CcSEcCtD
Degarelix—Insomnia—Methotrexate—bone cancer	0.000104	0.00191	CcSEcCtD
Degarelix—Arthralgia—Doxorubicin—bone cancer	0.000104	0.00191	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000103	0.0019	CcSEcCtD
Degarelix—Discomfort—Doxorubicin—bone cancer	0.000102	0.00189	CcSEcCtD
Degarelix—Dyspnoea—Methotrexate—bone cancer	0.000102	0.00189	CcSEcCtD
Degarelix—Dry mouth—Doxorubicin—bone cancer	0.000101	0.00187	CcSEcCtD
Degarelix—Hypotension—Epirubicin—bone cancer	0.0001	0.00185	CcSEcCtD
Degarelix—Decreased appetite—Methotrexate—bone cancer	9.97e-05	0.00184	CcSEcCtD
Degarelix—Anaphylactic shock—Doxorubicin—bone cancer	9.93e-05	0.00183	CcSEcCtD
Degarelix—Gastrointestinal disorder—Methotrexate—bone cancer	9.9e-05	0.00183	CcSEcCtD
Degarelix—Fatigue—Methotrexate—bone cancer	9.89e-05	0.00182	CcSEcCtD
Degarelix—Pain—Methotrexate—bone cancer	9.81e-05	0.00181	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Epirubicin—bone cancer	9.78e-05	0.0018	CcSEcCtD
Degarelix—Nervous system disorder—Doxorubicin—bone cancer	9.74e-05	0.0018	CcSEcCtD
Degarelix—Insomnia—Epirubicin—bone cancer	9.71e-05	0.00179	CcSEcCtD
Degarelix—Skin disorder—Doxorubicin—bone cancer	9.65e-05	0.00178	CcSEcCtD
Degarelix—Hyperhidrosis—Doxorubicin—bone cancer	9.6e-05	0.00177	CcSEcCtD
Degarelix—Dyspnoea—Epirubicin—bone cancer	9.57e-05	0.00177	CcSEcCtD
Degarelix—Feeling abnormal—Methotrexate—bone cancer	9.45e-05	0.00174	CcSEcCtD
Degarelix—Gastrointestinal pain—Methotrexate—bone cancer	9.38e-05	0.00173	CcSEcCtD
Degarelix—Decreased appetite—Epirubicin—bone cancer	9.33e-05	0.00172	CcSEcCtD
Degarelix—Hypotension—Doxorubicin—bone cancer	9.28e-05	0.00171	CcSEcCtD
Degarelix—Gastrointestinal disorder—Epirubicin—bone cancer	9.27e-05	0.00171	CcSEcCtD
Degarelix—Fatigue—Epirubicin—bone cancer	9.25e-05	0.00171	CcSEcCtD
Degarelix—Pain—Epirubicin—bone cancer	9.18e-05	0.00169	CcSEcCtD
Degarelix—Constipation—Epirubicin—bone cancer	9.18e-05	0.00169	CcSEcCtD
Degarelix—Urticaria—Methotrexate—bone cancer	9.11e-05	0.00168	CcSEcCtD
Degarelix—Body temperature increased—Methotrexate—bone cancer	9.07e-05	0.00167	CcSEcCtD
Degarelix—Abdominal pain—Methotrexate—bone cancer	9.07e-05	0.00167	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Doxorubicin—bone cancer	9.05e-05	0.00167	CcSEcCtD
Degarelix—Insomnia—Doxorubicin—bone cancer	8.98e-05	0.00166	CcSEcCtD
Degarelix—Dyspnoea—Doxorubicin—bone cancer	8.85e-05	0.00163	CcSEcCtD
Degarelix—Feeling abnormal—Epirubicin—bone cancer	8.84e-05	0.00163	CcSEcCtD
Degarelix—Gastrointestinal pain—Epirubicin—bone cancer	8.78e-05	0.00162	CcSEcCtD
Degarelix—Decreased appetite—Doxorubicin—bone cancer	8.63e-05	0.00159	CcSEcCtD
Degarelix—Gastrointestinal disorder—Doxorubicin—bone cancer	8.57e-05	0.00158	CcSEcCtD
Degarelix—Fatigue—Doxorubicin—bone cancer	8.56e-05	0.00158	CcSEcCtD
Degarelix—Urticaria—Epirubicin—bone cancer	8.53e-05	0.00157	CcSEcCtD
Degarelix—Pain—Doxorubicin—bone cancer	8.49e-05	0.00157	CcSEcCtD
Degarelix—Constipation—Doxorubicin—bone cancer	8.49e-05	0.00157	CcSEcCtD
Degarelix—Abdominal pain—Epirubicin—bone cancer	8.48e-05	0.00157	CcSEcCtD
Degarelix—Body temperature increased—Epirubicin—bone cancer	8.48e-05	0.00157	CcSEcCtD
Degarelix—Hypersensitivity—Methotrexate—bone cancer	8.45e-05	0.00156	CcSEcCtD
Degarelix—Asthenia—Methotrexate—bone cancer	8.23e-05	0.00152	CcSEcCtD
Degarelix—Feeling abnormal—Doxorubicin—bone cancer	8.18e-05	0.00151	CcSEcCtD
Degarelix—Gastrointestinal pain—Doxorubicin—bone cancer	8.12e-05	0.0015	CcSEcCtD
Degarelix—Pruritus—Methotrexate—bone cancer	8.11e-05	0.0015	CcSEcCtD
Degarelix—Hypersensitivity—Epirubicin—bone cancer	7.91e-05	0.00146	CcSEcCtD
Degarelix—Urticaria—Doxorubicin—bone cancer	7.89e-05	0.00146	CcSEcCtD
Degarelix—Abdominal pain—Doxorubicin—bone cancer	7.85e-05	0.00145	CcSEcCtD
Degarelix—Body temperature increased—Doxorubicin—bone cancer	7.85e-05	0.00145	CcSEcCtD
Degarelix—Diarrhoea—Methotrexate—bone cancer	7.85e-05	0.00145	CcSEcCtD
Degarelix—Asthenia—Epirubicin—bone cancer	7.7e-05	0.00142	CcSEcCtD
Degarelix—Pruritus—Epirubicin—bone cancer	7.59e-05	0.0014	CcSEcCtD
Degarelix—Dizziness—Methotrexate—bone cancer	7.58e-05	0.0014	CcSEcCtD
Degarelix—Diarrhoea—Epirubicin—bone cancer	7.34e-05	0.00135	CcSEcCtD
Degarelix—Hypersensitivity—Doxorubicin—bone cancer	7.32e-05	0.00135	CcSEcCtD
Degarelix—Vomiting—Methotrexate—bone cancer	7.29e-05	0.00135	CcSEcCtD
Degarelix—Rash—Methotrexate—bone cancer	7.23e-05	0.00133	CcSEcCtD
Degarelix—Dermatitis—Methotrexate—bone cancer	7.22e-05	0.00133	CcSEcCtD
Degarelix—Headache—Methotrexate—bone cancer	7.18e-05	0.00133	CcSEcCtD
Degarelix—Asthenia—Doxorubicin—bone cancer	7.12e-05	0.00131	CcSEcCtD
Degarelix—Dizziness—Epirubicin—bone cancer	7.1e-05	0.00131	CcSEcCtD
Degarelix—Pruritus—Doxorubicin—bone cancer	7.03e-05	0.0013	CcSEcCtD
Degarelix—Vomiting—Epirubicin—bone cancer	6.82e-05	0.00126	CcSEcCtD
Degarelix—Nausea—Methotrexate—bone cancer	6.81e-05	0.00126	CcSEcCtD
Degarelix—Diarrhoea—Doxorubicin—bone cancer	6.79e-05	0.00125	CcSEcCtD
Degarelix—Rash—Epirubicin—bone cancer	6.77e-05	0.00125	CcSEcCtD
Degarelix—Dermatitis—Epirubicin—bone cancer	6.76e-05	0.00125	CcSEcCtD
Degarelix—Headache—Epirubicin—bone cancer	6.72e-05	0.00124	CcSEcCtD
Degarelix—Dizziness—Doxorubicin—bone cancer	6.57e-05	0.00121	CcSEcCtD
Degarelix—Nausea—Epirubicin—bone cancer	6.37e-05	0.00118	CcSEcCtD
Degarelix—Vomiting—Doxorubicin—bone cancer	6.31e-05	0.00116	CcSEcCtD
Degarelix—Rash—Doxorubicin—bone cancer	6.26e-05	0.00116	CcSEcCtD
Degarelix—Dermatitis—Doxorubicin—bone cancer	6.26e-05	0.00115	CcSEcCtD
Degarelix—Headache—Doxorubicin—bone cancer	6.22e-05	0.00115	CcSEcCtD
Degarelix—Nausea—Doxorubicin—bone cancer	5.9e-05	0.00109	CcSEcCtD
